Company Filing History:
4 out of 69 
1 out of 1 Years Active: 2011-2016
Title: The Innovative Work of David H Peyton: Revolutionizing Malaria Treatment
Introduction:
David H Peyton, a pioneering inventor based in Portland, OR, has made significant contributions to the field of medicine with his groundbreaking research on combating malaria. With a total of 4 patents to his name, Peyton's work is reshaping the landscape of antimalarial treatments.
Latest Patents:
1. Quinoline derivatives and uses thereof: Peyton's innovative disclosure introduces a novel class of compounds known as 'reversed chloroquines' (RCQs), which exhibit high efficacy against both chloroquine-resistant (CQ) and chloroquine-sensitive (Cq) malaria parasites. These hybrid molecules combine an antimalarial quinoline analog with a CQ reversal moiety, offering new possibilities for malaria treatment.
2. Modified chloroquines with single ring moiety or fused ring moiety: Peyton's patent presents modified chloroquine compounds featuring single or fused ring moieties. These compounds, along with associated pharmaceutical compositions, provide promising avenues for inhibiting diseases caused by CQ-resistant and CQ-susceptible malaria parasites and other microorganisms.
Career Highlights:
Having worked with the State of Oregon Acting by and Through the State Board of Higher Education on Behalf of Portland State University, Peyton has leveraged his expertise to advance research and development in antimalarial therapies. His dedication to innovation has earned him recognition as a leading figure in the fight against malaria.
Collaborations:
Throughout his career, Peyton has collaborated with esteemed colleagues such as Steven Burgess and Katherine M Liebman. Together, they have shared knowledge, expertise, and a common goal of improving global health through innovative medical solutions.
Conclusion:
David H Peyton's relentless pursuit of innovation in the field of medicine has led to the development of pioneering antimalarial compounds that have the potential to revolutionize malaria treatment. His patents stand as a testament to his dedication to pushing boundaries and creating impactful solutions for public health challenges.